Side by side
Consultation participation and their own register declarations, side by side. Counts, not judgments — participation is not influence.
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
NGO · United States
Declared costs: not declared · in the register since 2016
Industry association · Belgium
Declared costs: €6M+ a year · in the register since 2009
Medicinal products for human use · European Centre for Disease Prevention and Control · Serious cross-border threats to health
Register facts self-declared (snapshot 2 Sept 2026); cost bands are floors. Shared files are shared attention, not evidence of coordination.
Their opening passages on the files they share, verbatim and in filing order. We do not summarize, compare, or characterize positions — read them at source.
EFPIA · filed 27 Apr 2021 · source
EFPIA supports an agile regulatory framework and a strong incentives’ system that embrace and encourage advances in science, technology & medicines. This evaluation is an opportunity to implement learnings from COVID-19 and ensure a competitive, world-class regulatory system in Europe supporting a globally competitive research-based industry at a critical time.
EFPIA · filed 3 Oct 2023 · source
EFPIA supports the objectives of enhancing the availability and accessibility of medicines, while fostering a competitive innovation environment in Europe. We welcome the proposal to future-proof the EU regulatory framework, maximising the use of expedited pathways, optimising regulatory decision-making processes, and reducing unnecessary administrative burdens.
EFPIA · filed 9 Oct 2023 · source
EFPIA supports the objectives of enhancing the availability and accessibility of medicines, while fostering a competitive innovation environment in Europe. We welcome the proposal to future-proof the EU regulatory framework, maximising the use of expedited pathways, optimising regulatory decision-making processes, and reducing unnecessary administrative burdens.
Global Alliance for Tuberculosis Drug Development (TB Alliance) · filed 8 Nov 2023 · source
TB Alliance welcomes the European Commissions proposed pharmaceutical package, especially with regards to: 1) addressing unmet medical needs, 2) proposing incentives to tackle antimicrobial resistance, 3) regulatory support, and 4) reporting on publicly funded financial support.
Global Alliance for Tuberculosis Drug Development (TB Alliance) · filed 2 Feb 2021 · source
TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster acting, and affordable tuberculosis (TB) drugs. It is part of a group of Product Development Partnerships (PDPs), which aim to address existing market failures by linking the public, private, and philanthropic sectors.
EFPIA · filed 2 Feb 2021 · source
EFPIA fully supports the EU’s goal to enhance its health emergency preparedness and response capacity by, among others, reinforcing the mandate of the ECDC. It is critically important that as part of its extended missions and tasks (art. 3), the ECDC can get full and immediate access to all epidemiological data from Member States.
Global Alliance for Tuberculosis Drug Development (TB Alliance) · filed 2 Feb 2021 · source
TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster acting, and affordable tuberculosis (TB) drugs. It is part of a group of Product Development Partnerships (PDPs), which aim to address existing market failures by linking the public, private, and philanthropic sectors.
EFPIA · filed 2 Feb 2021 · source
EFPIA fully supports the EU’s goal to enhance its health emergency preparedness and response capacity. We welcome the proposed Regulation strengthening Europe’s preparedness against serious cross-border health threats, and believe that it can be improved further to ensure it delivers on its objectives.
2 organizations on one sheet: every file each filed on, their register declarations, and a working link to each submission. Free: we ask for your name and email, and PolicySpeak may contact you about the product (privacy policy). The per-file record stays downloadable without signing up on each file’s page.